Brief: Aiforia Signs Agreement With South Korean Biotech Company
Feb 15 (Reuters) - Aiforia Technologies Oyj AIFORIA.HE :
* AIFORIA SIGNS AGREEMENT WITH SOUTH KOREAN BIOTECH COMPANY
TO
AUGMENT ITS NOVEL DRUG DISCOVERY PLATFORM WITH AI
* AIFORIA AND GENUV WILL COLLABORATE TO INTEGRATE AIFORIA'S
DEEP
LEARNING AI INTO GENUV'S ATRIVIEW DISCOVERY PLATFORM
Source text for Eikon: ID:nWkr7Rqwsq
Further company coverage: AIFORIA.HE
(Gdansk Newsroom)
((gdansk.newsroom@thomsonreuters.com; +48 58 7696600;))
Recent news on Aiforia Technologies Oyj
See all newsBrief: Aiforia Collaborates with PathAI
Brief: Aiforia Technologies H1 EBITDA Loss €4.73 Mln
Brief: Aiforia And Stratipath Partner To Expand Access To Ai-Driven Precision Diagnostics In Oncology
Brief: Aiforia Technologies To Provide Ai-Assisted Diagnostic Solutions
Brief: Aiforia Technologies Elects Tuomas Tenkanen As Chairman